We use cookies. You have options. Cookies help us keep the site running smoothly and inform some of our advertising, but if you’d like to make adjustments, you can visit our Cookie Notice page for more information.
We’d like to use cookies on your device. Cookies help us keep the site running smoothly and inform some of our advertising, but how we use them is entirely up to you. Accept our recommended settings or customise them to your wishes.

Digital Pharma East

September 17 - 20 | Philadelphia, PA

Event Details

The Health industry today is turbulent with competing, game changing distractions including: mergers & acquisitions like CVS/Aetna, Walgreens/Humana, new start-ups and the looming threat of Amazon's impact. There’s a fear of the unknown. As such, today’s health brands are facing a crucial transformation in the new era of people-based marketing. Disruptions have changed customer expectations and now, experience is everything.

As a participating as a sponsor at Digital Pharma East, schedule time to meet with our team to understand how partnering with Merkle Health will position you to deliver improved acquisition, optimized retention and improved shareholder value. Email us at [email protected] to find a time that works for you.

Hoping to attend? Use the code DPE19SPN to get 15% off your event registration!

Our Sessions

Location: Pennsylvania Convetion Center
Date/Time: 12:10pm, September 19

Discussion between panelists from Otsuka Pharmaceuticals, Bristol-Myers Squibb, Demandbase and Merkle will address such questions as:

  1. What are the key components?
  2. What is critical to delivering a seamless customer experience?
  3. What do you standardize and what do you localize?
  4. Where is value derived for customers and for enterprises?
Serge Del Grosso

Serge Del Grosso

SVP Media Solutions & Strategy

Date/Time: 9:40am, September 19

One of the biggest challenges that faces launch brands in unique therapeutic areas is identifying the right target audience for unbranded and ultimately branded messaging. While some treatment options may be more intuitive than others, it is still a critical consideration that can impact speed to market, awareness and trial, business impact and ROI. This session will discuss the migration of HCPs from initial touch to progressively increasing levels of engagement leading to defined levels of Rx activity. 


Jane Portman

SVP, Vertical Practice Lead – Health & Non-Profit, Merkle

Kent Groves, PhD,

SVP Client Strategy